Mode of action and human relevance assessment of male CD‐1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin
- 18 April 2022
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 42 (10) , 1570-1584
Abstract
Inhibition of sodium‐glucose cotransporter‐2 (SGLT2) has been shown to be a safe and efficacious approach to support managing Type 2 diabetes. In the 2‐year carcinogenicity study with the SGLT2 inhibitor empagliflozin in CD‐1 mice, an increased incidence of renal tubular adenomas and carcinomas was identified in the male high‐dose group but was not observed in female mice. An integrated review of available nonclinical data was conducted to establish a mode‐of‐action hypothesis for male mouse‐specific tumorigenesis. Five key events were identified through systematic analysis to form the proposed mode‐of‐action: (1) Background kidney pathology in CD‐1 mice sensitizes the strain to (2) pharmacology‐related diuretic effects associated with SGLT2 inhib ition. (3) In male mice, metabolic demand increases with the formation of a sex‐ and species‐specific empagliflozin metabolite. These features converge to (4) deplete oxidative stress handling reserve, driving (5) constitutive cellular proliferation in male CD‐1 mice. The proposed mode of action requires all five key events for empagliflozin to present a carcinogenicity risk in the CD‐1 mouse. Considering that empagliflozin is not genotoxic in the standard battery of genotoxicity tests, and not all five key events are present in the context of female mice, rats, or humans, nor for other osmotic diuretics or other SGLT2 inhibitors, the observed male mouse renal tumors are not considered relevant to humans.Keywords
This publication has 53 references indexed in Scilit:
- Consideration of Rat Chronic Progressive Nephropathy in Regulatory Evaluations for CarcinogenicityToxicological Sciences, 2012
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal TubuleJournal of the American Society of Nephrology, 2011
- The Sweet Pee Model for Sglt2 MutationJournal of the American Society of Nephrology, 2011
- Mechanotransduction in the renal tubuleAmerican Journal of Physiology-Renal Physiology, 2010
- Shear stress-induced changes of membrane transporter localization and expression in mouse proximal tubule cellsProceedings of the National Academy of Sciences, 2010
- SGLT2 inhibition — a novel strategy for diabetes treatmentNature Reviews Drug Discovery, 2010
- Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulationApoptosis, 2007
- Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restrictionAmerican Journal of Physiology-Renal Physiology, 2007
- Juvenile cystic kidneys (jck): A new mouse mutation which causes polycystic kidneysKidney International, 1993
- Age-related increased susceptibility of male Fischer 344 rats to acetaminophen nephrotoxicityLife Sciences, 1986